8-KLeadership Changes

AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Jan 18, 2011)

Filed January 18, 2011For Securities:A

Summary

Agilent Technologies, Inc. has announced a change in its Board of Directors through an 8-K filing dated January 18, 2011, reporting an event on January 12, 2011. The company's Board size has been increased from 8 to 9 members with the election of Dr. Tadataka Yamada. Dr. Yamada's appointment is effective immediately, and he will serve until the 2013 Annual Meeting of Stockholders, filling a vacancy that has been created. Dr. Yamada will bring his expertise to key board committees, specifically the Compensation Committee and the Nominating/Corporate Governance Committee. The filing clarifies that there are no undisclosed arrangements or material interests between Dr. Yamada and the company that require further disclosure under SEC regulations. This expansion and appointment suggest a strategic reinforcement of the board's oversight and governance capabilities.

Key Highlights

  • 1Agilent Technologies, Inc. expanded its Board of Directors from 8 to 9 members.
  • 2Dr. Tadataka Yamada was elected to fill the newly created vacancy on the Board.
  • 3Dr. Yamada's term will extend until the 2013 Annual Meeting of Stockholders.
  • 4Dr. Yamada will serve on the Compensation Committee.
  • 5Dr. Yamada will also serve on the Nominating/Corporate Governance Committee.
  • 6There are no reportable related-party transactions or arrangements involving Dr. Yamada.
  • 7The board size increase was recommended by the Nominating/Corporate Governance Committee.

Frequently Asked Questions

The Board of Directors was increased from 8 to 9 members to accommodate the appointment of Dr. Tadataka Yamada, suggesting a strategic decision to enhance board capacity or expertise.

While the 8-K filing does not detail Dr. Yamada's specific background or qualifications, his appointment to the Compensation and Nominating/Corporate Governance committees indicates that the board values his expertise in these areas.

No, the filing explicitly states that there are no arrangements or understandings with Dr. Yamada regarding his appointment, nor are there any material transactions to which Agilent is a party in which Dr. Yamada has a material interest that need to be disclosed under Regulation S-K.

Dr. Yamada was elected to serve in the class of directors that will stand for re-election at the 2013 Annual Meeting of Stockholders.